Generic, Branded Generic and Proprietary Medicinal Products — Group 8 [3111381]

A Contract Award Notice
by BUSINESS SERVICES ORGANISATION, PROCUREMENT & LOGISTICS SERVICE

Source
OJEU
Type
Contract (Supply)
Duration
5 year (est.)
Value
£6M
Sector
HEALTH
Published
28 Sep 2021
Delivery
To 14 Dec 2030 (est.)
Deadline
n/a

Concepts

Location

Belfast

Geochart for 2 buyers and 27 suppliers

Description

Generic, Branded Generic and Proprietary Medicinal Products — Group 8 [3111381]

Total Quantity or Scope

Generic, Branded Generic and Proprietary Medicinal Products — Group 8 [3111381] is established under the Medicinal Products Dynamic Purchasing System [131864]. The contract is awarded on behalf of the following contract participants: (i) Belfast Health and Social Care Trust (BHSCT); (ii) South Eastern Health and Social Care Trust (SEHSCT); (iii) Northern Health and Social Care Trust (NHSCT); (iv) Southern Health and Social Care Trust (SHSCT); (v) Western Health and Social Care Trust (WHSCT); (vi) Northern Ireland Ambulance Service (NIAS); (vii) Northern Ireland Blood Transfusion Service (NIBTS); (viii) Business Services Organisation (BSO); (ix) Public Health Agency (PHA); (x) Department of Health, Northern Ireland (DoH(NI)); (xi) Health and Social Care Board (HSCB).

Award Detail

1 Abbvie (Maidenhead)
  • Num offers: 40
  • Value: £210,352
2 Alliance Pharmaceuticals (Chippenham)
  • Num offers: 40
  • Value: £299,649
  • Contractor is an SME.
3 Astellas Pharma (Woking)
  • Num offers: 40
  • Value: £343,266
4 Baxter Healthcare (Thetford)
  • Num offers: 40
  • Value: £198,612
5 Chiesi (Manchester)
  • Num offers: 40
  • Value: £29,897
  • Contractor is an SME.
6 Desitin Pharma (Woking)
  • Num offers: 40
  • Value: £5,809
  • Contractor is an SME.
7 Focus Pharmaceuticals (London)
  • Num offers: 40
  • Value: £8,789
  • Contractor is an SME.
8 Fresenius Kabi (Runcorn)
  • Num offers: 40
  • Value: £29,327
9 Glaxosmithkline (Brentford)
  • Num offers: 40
  • Value: £40,347
10 Hameln Pharma (Gloucester)
  • Num offers: 40
  • Value: £59,107
  • Contractor is an SME.
11 Intrapharm Laboratories (Maidenhead)
  • Num offers: 40
  • Value: £79,580
  • Contractor is an SME.
12 Janssen Cilag (High Wycombe)
  • Num offers: 40
  • Value: £1,921,082
13 Kent Pharma (Heathrow)
  • Num offers: 40
  • Value: £139,728
  • Contractor is an SME.
14 Kyowa Kirin (Galashiels)
  • Num offers: 40
  • Value: £62,832
  • Contractor is an SME.
15 Martindale Pharma (Romford)
  • Num offers: 40
  • Value: £158,041
16 Morningside Pharmaceuticals (Loughborough)
  • Num offers: 40
  • Value: £413,326
  • Contractor is an SME.
17 Mylan (Hatfield)
  • Num offers: 40
  • Value: £87,455
18 Norgine Pharmaceuticals (Uxbridge)
  • Num offers: 40
  • Value: £63,179
  • Contractor is an SME.
19 Novartis Pharmaceuticals (London)
  • Num offers: 40
  • Value: £1,001,520
20 Pfizer (Sandwich)
  • Num offers: 40
  • Value: £145,789
21 Ranbaxy (Hayes)
  • Num offers: 40
  • Value: £103,901
  • Contractor is an SME.
22 Teva (Castleford)
  • Num offers: 40
  • Value: £46,586
23 Torbay Pharmaceuticals (Paignton)
  • Num offers: 40
  • Value: £57,954
24 Typharm (Norwich)
  • Num offers: 40
  • Value: £54,737
  • Contractor is an SME.
25 Ucb Pharma (Slough)
  • Num offers: 40
  • Value: £151,760
26 Wockhardt (Wrexham)
  • Num offers: 40
  • Value: £16,278
27 Zentiva (London)
  • Num offers: 40
  • Value: £79,293

Award Criteria

Compliance with Contract Scope and Specification _
Supply and Delivery of Product: Same Working Day Delivery 5.0
Supply and Delivery of Product: Wholesale Distribution 5.0
Continuity of Supply: Minimum Committed Stockholding 8.0
Governance, Quality Control and Risk: Pharmaceutical Quality Assessment (PQA) Section 1 _
Governance, Quality Control and Risk: Pharmaceutical Quality Assessment (PQA) Section 2 – Section 6 (inclusive) 40.0
PRICE 42.0

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price and quality.

Other Information

The estimated total value of contract (excluding VAT) is GBP 5 500 000 to GBP 33 750 000. This estimated total value figure takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts document and provides for potential growth of up to 50% over the course of the contract. The total value of contract (detailed in section V.2.4)) awarded to each of the contractors indicated in this notice is based on an initial contract period of 24 months. It is important to note that there is available provision to extend this initial contract period in accordance with Section 2 of the SS17bc Commercial Conditions of Contract for Supplies Contracts document.

Reference

Domains